Catcholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment

被引:97
作者
Carmignani, M
Volpe, AR
Boscolo, P
Qiao, N
Di Gioacchino, M
Grilli, A
Felaco, M
机构
[1] Univ Aquila, Dept Basic & Appl Biol, Pharmacol Sect, I-67010 Coppito, AQ, Italy
[2] Univ Cattolica Sacro Cuore, Sch Med, CNR, Receptor Chem Ctr, I-00168 Rome, Italy
[3] Univ G DAnnunzio, Dept Med & Sci Aging, Ctr Occupat Med & Ergoftalmol, I-66100 Chieti, Italy
[4] Shanxi Med Univ, Dept Occupat Hlth, Taiyuan 030001, Peoples R China
[5] Univ G DAnnunzio, Unit Clin Immunol & Allergol, I-66100 Chieti, Italy
[6] Univ G DAnnunzio, Inst Biomorphol, I-66100 Chieti, Italy
关键词
chronic lead exposure; catecholamines; nitric oxide; blood hypertension; autonomic nervous system;
D O I
10.1016/S0024-3205(00)00954-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Rats were exposed for ten months to 60 ppm of lead (Pb, as acetate) in drinking water to further assess cardiovascular effects of chronic Pb exposure. At the end of the treatment, mean blood Pb was 3.1+/-0.3 mug/dL in the control rats and 22.8+/-1.2 mug/dL in the Pb-exposed rats (means+/-SE, n=12 in each group); these values were not comparable to those of humans. Pb greatly increased plasma levels of noradrenaline (NA) and adrenaline (A), but not those of L-DOPA and dopamine; monoaminoxidase activity was augmented by Pb, mostly in the aorta and in the liver; the aorta, liver, heart and kidney showed discrete histopathological alterations in the Pb-exposed fats, in which plasma levels of nitric oxide (NO, determined as L-citrulline) were reduced. Pb was able to induce blood hypertension, resulting from increase of cardiac inotropism and, mostly, total peripheral resistance. These data were discussed also in relation to those obtained in our previous studies carried out in rats exposed to Pb in drinking water (15-60 ppm) for periods ranging from five to eighteen months. Pb appeared to increase both sympathetic nerve activity by central mechanisms (thus increasing plasma NA and A) and cyclic adenosine monophosphate (cAMP)-dependent availability of calcium ions (Ca++) for contractile mechanisms in the vascular and cardiac myocells (also through an increased vascular alpha (2)- and myocardial beta (1)-adrenoreceptor reactivity). The reduction of plasma NO, contributing to increase vascular resistance and cardiac inotropism, was explained as a result of actions of Pb on enzyme activities concerned with the kallikrein-kinin (KK) and renin-angiotensin-aldosterone (RAA) systems. It was concluded that chronic Pb exposure is able to affect selective neuroendocrine (i,e., catecholamine), autacoidal (i.e., KK and RAA) and transductional pathways (i.e., cAMP, NO, Ca++) involved in the cardiovascular function. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:401 / 415
页数:15
相关论文
共 61 条
[51]   LEAD-POISONING - ALTERED URINARY CATECHOLAMINE METABOLITES AS INDICATORS OF INTOXICATION IN MICE AND CHILDREN [J].
SILBERGELD, EK ;
CHISOLM, JJ .
SCIENCE, 1976, 192 (4235) :153-155
[52]   ACTIVATION OF PROTEIN-KINASE-C ISOZYMES BY CONTRACTILE STIMULI IN ARTERIAL SMOOTH-MUSCLE [J].
SINGER, HA ;
SCHWORER, CM ;
SWEELEY, C ;
BENSCOTER, H .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 299 (02) :320-329
[53]  
Sokas RK, 1997, AM J IND MED, V31, P188
[54]  
STAESSEN JA, 1995, J HUM HYPERTENS, V9, P303
[55]   THE PROTEIN-KINASE-C FAMILY FOR NEURONAL SIGNALING [J].
TANAKA, C ;
NISHIZUKA, Y .
ANNUAL REVIEW OF NEUROSCIENCE, 1994, 17 :551-567
[56]   Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: Effect of lazaroid therapy [J].
Vaziri, ND ;
Ding, YX ;
Ni, ZM ;
Gonick, HC .
KIDNEY INTERNATIONAL, 1997, 52 (04) :1042-1046
[58]   Regulatory role of bradykinin in the coronary and cerebral circulations and in systemic hemodynamics [J].
Volpe, AR ;
Fontecchio, G ;
Carmignani, M .
IMMUNOPHARMACOLOGY, 1999, 44 (1-2) :87-92
[59]   Biosynthesis of endothelium-derived nitric oxide by bradykinin as endogenous precursor [J].
Volpe, AR ;
Giardina, B ;
Preziosi, P ;
Carmignani, M .
IMMUNOPHARMACOLOGY, 1996, 33 (1-3) :287-290
[60]  
ZHENG YX, 1994, CHINESE J PREVENTIVE, V28, P281